Zhejiang Lanyu Digital Technology
301585
BBK Test Systems
301598
MEIZHIGAO
834765
Youkeshu Technology
300209
Hangzhou Raycloud Technology Co.,Ltd
688365
CN Stock MarketDetailed Quotes
300267 Hunan Er-kang Pharmaceutical
- 3.23
- +0.02+0.62%
Market Closed Dec 20 15:00 CST
6.66BMarket Cap-25.63P/E (TTM)
3.27High3.17Low301.08KlotVolume3.20Open3.21Pre Close96.91MTurnover2.12%Turnover RatioLossP/E (Static)2.06BShares3.8852wk High1.41P/B4.59BFloat Cap2.0352wk Low3.85Limit Up1.42BShs Float23.06Historical High2.57Limit Down3.12%Amplitude1.20Historical Low--Dividend TTM3.22Avg Price153.58KlotAsk--Div YieldTTM100Lot Size143.69KlotBid
Hunan Er-kang Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -40.89%854.29M | -40.83%621.35M | -49.57%275.79M | -4.67%1.78B | 9.71%1.45B | 20.63%1.05B | 28.28%546.93M | -16.32%1.87B | -16.69%1.32B | 4.58%870.55M |
| Operating revenue | -40.89%854.29M | -40.83%621.35M | -49.57%275.79M | -4.67%1.78B | 9.71%1.45B | 20.63%1.05B | 28.28%546.93M | -16.32%1.87B | -16.69%1.32B | 4.58%870.55M |
| Other operating revenue | ---- | -65.11%6.6M | ---- | 57.61%16.76M | ---- | 589.50%18.91M | ---- | 65.29%10.63M | ---- | -0.71%2.74M |
| Total operating cost | -38.74%893.55M | -39.40%626.82M | -45.10%288.33M | 0.76%1.9B | 12.14%1.46B | 21.91%1.03B | 28.88%525.22M | -14.46%1.88B | -9.58%1.3B | 13.93%848.4M |
| Operating cost | -45.95%589.96M | -44.92%432.64M | -54.28%193.4M | -2.47%1.42B | 7.71%1.09B | 19.86%785.44M | 33.16%423M | -15.09%1.45B | -7.61%1.01B | 25.97%655.27M |
| Operating tax surcharges | -12.73%12.55M | -13.56%9.03M | 28.33%4.47M | 16.12%13.92M | 80.83%14.38M | 106.68%10.45M | 65.03%3.48M | -6.47%11.99M | -22.26%7.95M | -30.84%5.06M |
| Operating expense | -18.64%72.76M | -28.73%48.12M | 13.94%25.38M | 23.39%138.5M | 31.72%89.43M | 70.65%67.52M | 47.73%22.27M | -4.77%112.24M | -27.73%67.9M | -28.34%39.56M |
| Administration expense | -15.04%186.07M | -18.32%117.47M | -10.30%57.43M | 10.71%267.38M | 29.13%219.01M | 15.03%143.82M | 5.69%64.02M | -19.97%241.51M | -15.45%169.6M | -9.00%125.03M |
| Financial expense | -154.69%-1.9M | -140.39%-1.64M | -128.84%-1.2M | -99.28%95.47K | -63.16%3.47M | 32.37%4.05M | 43.98%4.15M | 155.01%13.21M | 166.47%9.43M | 103.30%3.06M |
| -Interest expense (Financial expense) | 49.47%8.26M | 37.17%6.26M | 19.86%3.76M | 21.12%6.66M | 80.93%5.53M | 153.11%4.57M | 97.08%3.14M | -40.76%5.5M | -61.56%3.05M | -66.38%1.8M |
| -Interest Income (Financial expense) | -19.01%-3.81M | -96.71%-2.93M | -149.84%-1.61M | -67.27%-4.13M | -104.01%-3.2M | -55.78%-1.49M | -52.87%-644.77K | 25.42%-2.47M | 41.32%-1.57M | 48.02%-954.98K |
| Research and development | -16.45%34.12M | -7.83%21.2M | 6.78%8.85M | 19.30%57.44M | 25.98%40.83M | 12.67%23M | -10.06%8.29M | -1.78%48.15M | -2.87%32.41M | -11.49%20.41M |
| Credit Impairment Loss | -91.88%776.62K | -76.93%2.22M | -88.86%567.4K | -260.58%-24.26M | 226.96%9.56M | 286.60%9.64M | 258.02%5.1M | -160.46%-6.73M | -308.53%-7.53M | -141.59%-5.17M |
| Asset Impairment Loss | -207.10%-339.14K | 65.32%849.38K | 111.78%1.33M | -1,931.02%-98.39M | -95.47%316.66K | -87.16%513.79K | -70.98%627.34K | 99.46%-4.84M | 270.90%6.99M | 251.02%4M |
| Other net revenue | -61.36%18.96M | -47.41%17.21M | 579.83%13.38M | -470.71%-93.58M | 70.38%49.08M | 79.34%32.71M | -219.56%-2.79M | 102.96%25.24M | -48.90%28.8M | -38.65%18.24M |
| Fair value change income | 102.14%302.8K | 109.46%419.8K | 104.29%563K | -202.97%-14.54M | -178.57%-14.12M | -164.30%-4.44M | ---13.14M | --14.12M | --17.97M | --6.9M |
| Invest income | -93.69%1.2M | 1,165.14%935.16K | 140.49%326.47K | 16.26%5.46M | 542.67%18.99M | -101.43%-87.8K | 25.06%-806.29K | -72.90%4.7M | -92.83%2.95M | -35.66%6.14M |
| -Including: Investment income associates | 95.07%-701.52K | 95.81%-571.66K | 97.55%-328.23K | -160.61%-18.74M | -133.05%-14.23M | -410.35%-13.65M | -787.90%-13.37M | 29.30%-7.19M | -253.85%-6.11M | -53,684.69%-2.67M |
| Asset deal income | -98.63%172.8K | ---- | ---- | 16,436.04%8.8M | 23,580.90%12.61M | 627,239.48%12.34M | ---- | -77.10%53.24K | -69.64%53.24K | -98.80%1.97K |
| Other revenue | -22.42%16.85M | -13.36%12.78M | 94.97%10.59M | 63.47%29.34M | 159.47%21.72M | 131.89%14.75M | 21.55%5.43M | -5.07%17.95M | -45.82%8.37M | -37.99%6.36M |
| Operating profit | -156.68%-20.3M | -75.85%11.73M | -95.57%838.83K | -1,600.20%-206.73M | -21.31%35.82M | 20.30%48.6M | -10.61%18.92M | 101.68%13.78M | -77.15%45.51M | -65.63%40.39M |
| Add:Non operating Income | -94.08%348.99K | -93.83%328.56K | -99.11%37.27K | 195.61%15.56M | 18.26%5.9M | 197.45%5.33M | 615.69%4.17M | 267.93%5.26M | 321.78%4.99M | 62.45%1.79M |
| Less:Non operating expense | 821.31%3.75M | 1,227.66%3.43M | -94.25%128.1K | 359.82%7.76M | -71.12%406.7K | -77.12%258.23K | 58,329.98%2.23M | -94.11%1.69M | -94.76%1.41M | -91.92%1.13M |
| Total profit | -157.37%-23.7M | -83.91%8.63M | -96.41%748K | -1,246.31%-198.93M | -15.86%41.31M | 30.71%53.67M | -4.05%20.86M | 102.05%17.35M | -71.70%49.09M | -60.77%41.06M |
| Less:Income tax cost | -81.59%3.19M | -81.70%2.3M | 154.30%1.03M | 216.22%22.92M | -7.73%17.34M | -9.81%12.55M | -79.22%406.5K | 58.52%-19.72M | 11.40%18.8M | 45.35%13.91M |
| Net profit | -212.22%-26.89M | -84.59%6.34M | -101.40%-285.7K | -698.36%-221.85M | -20.90%23.96M | 51.47%41.12M | 3.39%20.46M | 104.64%37.08M | -80.66%30.29M | -71.45%27.15M |
| Net profit from continuing operation | -212.22%-26.89M | -84.59%6.34M | -101.40%-285.7K | -698.36%-221.85M | -20.90%23.96M | 51.47%41.12M | 3.39%20.46M | 104.64%37.08M | -80.66%30.29M | -71.45%27.15M |
| Less:Minority Profit | 91.17%-1.42M | 100.35%38.18K | 43.32%-3.19M | -199.18%-26.53M | -167.70%-16.11M | -268.12%-10.83M | -104.63%-5.62M | -26.12%-8.87M | -312.32%-6.02M | -287.65%-2.94M |
| Net profit of parent company owners | -163.55%-25.47M | -87.87%6.3M | -88.87%2.9M | -525.12%-195.32M | 10.36%40.07M | 72.66%51.95M | 15.73%26.08M | 105.81%45.94M | -77.03%36.31M | -67.82%30.09M |
| Earning per share | ||||||||||
| Basic earning per share | -163.40%-0.0123 | -87.70%0.0031 | -88.89%0.0014 | -524.66%-0.0947 | 10.23%0.0194 | 72.60%0.0252 | 15.60%0.0126 | 105.81%0.0223 | -77.02%0.0176 | -67.77%0.0146 |
| Diluted earning per share | -163.40%-0.0123 | -87.70%0.0031 | -88.89%0.0014 | -524.66%-0.0947 | 10.23%0.0194 | 72.60%0.0252 | 15.60%0.0126 | 105.81%0.0223 | -77.02%0.0176 | -67.77%0.0146 |
| Other composite income | -257.82%-85.01M | -160.36%-38.77M | -48.74%-33.94M | -80.64%28.89M | -70.52%53.87M | -25.70%64.23M | -245.22%-22.82M | 464.71%149.22M | 1,647.95%182.72M | 535.34%86.44M |
| Other composite income of parent company owners | -258.85%-84.98M | -160.85%-38.8M | -50.34%-33.95M | -80.62%28.66M | -70.43%53.49M | -25.51%63.76M | -244.76%-22.58M | 464.61%147.88M | 1,646.77%180.92M | 534.73%85.6M |
| Other composite income of minority owners | -109.44%-35.05K | -92.65%34.03K | 105.86%13.73K | -82.96%226.81K | -79.40%371.35K | -44.92%462.99K | -297.14%-234.35K | 477.07%1.33M | 1,775.68%1.8M | 608.03%840.55K |
| Total composite income | -243.78%-111.9M | -130.78%-32.43M | -1,349.71%-34.22M | -203.58%-192.96M | -63.46%77.83M | -7.26%105.35M | -117.92%-2.36M | 122.20%186.29M | 47.10%213.01M | 51.00%113.59M |
| Total composite income of parent company owners | -218.04%-110.45M | -128.09%-32.5M | -987.80%-31.05M | -185.98%-166.66M | -56.93%93.57M | 0.02%115.72M | -78.12%3.5M | 123.30%193.83M | 48.40%217.23M | 56.72%115.69M |
| Total composite income of minority owners | 90.74%-1.46M | 100.70%72.21K | 45.83%-3.17M | -249.02%-26.3M | -273.35%-15.74M | -393.30%-10.37M | -108.68%-5.86M | -2.06%-7.54M | -169.01%-4.22M | -249.86%-2.1M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
